Chronic Inflammation-Related HPV: A Driving Force Speeds Oropharyngeal Carcinogenesis

PLoS One. 2015 Jul 20;10(7):e0133681. doi: 10.1371/journal.pone.0133681. eCollection 2015.

Abstract

Oropharyngeal squamous cell carcinoma (OPSCC) has been known to be a highly aggressive disease associated with human papilloma virus (HPV) infection. To investigate the relationship between HPV and chronic inflammation in oropharyngeal carcinogenesis, we collected 140 oral mucous fresh specimens including 50 OPSCC patients, 50 cancer in situ, 30 precancerous lesions, and 10 normal oral mucous. Our data demonstrated that there was a significantly higher proportion of severe chronic inflammation in dysplastic epithelia in comparison with that in normal tissues (P<0.001). The positive rate of HPV 16 was parallel with the chronic inflammation degrees from mild to severe inflammation (P<0.05). The positive rate of HPV 16 was progressively improved with the malignant progression of oral mucous (P<0.05). In addition, CD11b+ LIN- HLA-DR-CD33+ MDSCs were a critical cell population that mediates inflammation response and immune suppression in HPV-positive OPSCC. These indicated that persistent chronic inflammation-related HPV infection might drive oropharyngeal carcinogenesis and MDSCs might pay an important role during this process. Thus, a combination of HPV infection and inflammation expression might become a helpful biomedical marker to predict oropharyngeal carcinogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Squamous Cell / complications*
  • Carcinoma, Squamous Cell / genetics
  • Carcinoma, Squamous Cell / virology
  • Chronic Disease
  • Disease Progression
  • Gene Expression
  • Host-Pathogen Interactions
  • Human papillomavirus 16 / physiology
  • Humans
  • Inflammation / complications*
  • Inflammation / genetics
  • Inflammation / virology
  • Inflammation Mediators / metabolism
  • Interferon-gamma / genetics
  • Interleukin-10 / genetics
  • Interleukin-12 / genetics
  • Interleukin-2 / genetics
  • Oropharyngeal Neoplasms / complications*
  • Oropharyngeal Neoplasms / genetics
  • Oropharyngeal Neoplasms / virology
  • Papillomavirus Infections / complications*
  • Papillomavirus Infections / genetics
  • Papillomavirus Infections / virology
  • Reverse Transcriptase Polymerase Chain Reaction
  • Risk Factors

Substances

  • Inflammation Mediators
  • Interleukin-2
  • Interleukin-10
  • Interleukin-12
  • Interferon-gamma

Grants and funding

This work was supported by National Natural Science Foundation of China grants (Nos. 81361120399, 81321002, 81272961, and 81372891) and by State Key Laboratory of Oral Diseases Special Funded Projects (SKLOD201512).